Slide 1: Q4 2021 Preliminary Financial Results
© 2022 The Joint Corp. All Rights Reserved. 1 Q4 2021 Preliminary Financial Results As of December 31, 2021 | Reported on February 24, 2022
Slide 2: Safe Harbor Statement
Safe Harbor Statement © 2022 The Joint Corp. All Rights Reserved. 2 Certain statements contained in this presentation are "forward - looking statements” about future events and expectations. Forward - looking statements are based on our beliefs, assumptions and expectations of industry trends, our f
Slide 3: Advancing Growth Strategy
Advancing Growth Strategy © 2022 The Joint Corp. All Rights Reserved. 3 Forging the Chiropractic Dream Accelerating the Pace of Clinic Growth Harnessing the Power of Our Data
Slide 4: Record Operating Metrics
Record Operating Metrics © 2022 The Joint Corp. All Rights Reserved. 4 1 New patient survey completed February 2021. 1.4M unique patients treated in 2021 807K new patients in 2021 10.9M adjustments in 2021 27% of new patients were new to chiropractic 1 85% system - wide gross sales from monthly memb
Slide 5: 2021: Strongest Year Ever
2021: Strongest Year Ever 5 Preliminary Change from 2021 2020 Revenue $81.2M Up 38% Op. Income $6.0M Up 9% Net Income $7.2M $(6.0)M Adjusted EBITDA 2 $13.3M Up 46% Unrestricted cash $19.5 M at December 31, 2021, compared to $20.6M Dec. 31, 2020 © 2022 The Joint Corp. All Rights Reserved. 1 Comparabl
Slide 6: Total Clinics Open and Franchise Licenses Sold
12 26 82 175 242 265 309 352 394 453 515 610 4 47 61 47 48 60 64 96 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TOTAL CLINICS OPEN Franchise Company Owned/Managed 156 Franchise Licenses Sold in 2021 - Up 29% YoY 130 Clinics Opened in 2021 - Up 78% YoY © 2022 The Joint Corp. All Right
Slide 7: Regional Developers Driving Franchise License Sales
81% sold by RDs in 2021 71% of clinics supported by 21 RDs at December 31, 2021 RDs cover 59% of Metropolitan Statistical Areas (MSAs) at December 31, 2021 37 99 126 121 156 Dec. 31, 2017 Dec. 31, 2018 Dec. 31, 2019 Dec. 31, 2020 Dec. 31, 2021 616 715 841 962 1118 Dec. 31, 2017 Dec. 31, 2018 Dec. 31
Slide 8: Marketing Driving Growth
Marketing Driving Growth 8 © 2022 The Joint Corp. All Rights Reserved. Annual Promotions • “Back Friday” package sale - up 27% • “End - of - Year” membership sale - up 42% 2022 National Brand Campaign “Don’t Do Pain. Do You.” • Targeting Millennial consumers, touting the power of chiropractic care f
Slide 9: Preparing to Leverage New IT Platform
Preparing to Leverage New IT Platform © 2022 The Joint Corp. All Rights Reserved. 9 Initiatives • Improvements to the user experience • Enhanced promotional capabilities • Advanced analytics • Marketing automation • Native mobile app • Elevated risk control measures
Slide 10: Q4 2021 Preliminary Financial Results
Q4 2021 Preliminary Financial Results 10 $ in M 1 Q4 2021 Q4 2020 Differences Revenue • Corporate clinics • Franchise fees $22.4 12.2 10.2 $17.0 9.2 7.8 $5.4 3.0 2.4 32% 33% 30% Cost of revenue 2.4 1.9 0.5 24% Sales and marketing 2.9 2.1 0.8 38% Depreciation and amortization 1.8 0.7 1.1 170% G&A 14.
Slide 11: Year-ended Dec. 31, 2021 Preliminary Financial Results
Year - ended Dec. 31, 2021 Preliminary Financial Results 11 $ in M 1 2021 2020 Differences Revenue • Corporate clinics • Franchise fees $81.2 44.8 36.4 $58.7 31.8 26.9 $22.5 13.0 9.5 38% 41% 35% Cost of revenue 8.5 6.5 2.0 31% Sales and marketing 11.4 7.8 3.6 46% Depreciation and amortization 6.1 2.
Slide 12: Providing 2022 Guidance
Providing 2022 Guidance 12 $ in M 2021 Actual 2022 Low Guidance 2022 High Guidance Revenues $81.2 $102.0 $106.0 Adjusted EBITDA 1 $13.3 $15.0 $17.0 New Franchised Clinic Openings 110 110 130 New Company - owned/Managed Clinics 2 32 30 40 © 2022 The Joint Corp. All Rights Reserved. 1 Reconciliation o
Slide 13: Advancing Growth Strategy
Advancing Growth Strategy © 2022 The Joint Corp. All Rights Reserved. 13 Forging the Chiropractic Dream Accelerating the Pace of Clinic Growth Harnessing the Power of Our Data
Slide 14: Resilient Business Model Drives Long-term Growth
Resilient Business Model Drives Long - term Growth 14 People will continue to seek more noninvasive, holistic ways to manage their pain. We’ll be there to treat them. System - wide Sales ($ in M) 70% CAGR 1 (2010 - 2020) The Joint Corp. 11 - yr. CAGR 67% 1 vs. Industry CAGR 5.4% 2* 1 For the period
Slide 15: Non-GAAP Measure Definition
Non - GAAP Measure Definition 15 This presentation includes non - GAAP financial measures. System - wide sales include sales at all clinics, whether operated by the company or by fran chisees. While franchised sales are not recorded as revenues by the company, management believes the information is
Slide 16: Q4 2021 Preliminary Segment Results
Q4 2021 Preliminary Segment Results 16 2021 Q4 © 2022 The Joint Corp. All Rights Reserved. $ in 000s
Slide 17: Year-ended Dec. 31, 2021 Preliminary Segment Results
Year - ended Dec. 31, 2021 Preliminary Segment Results 17 2021 © 2021 The Joint Corp. All Rights Reserved. $ in 000s
Slide 18: Preliminary GAAP – Non-GAAP Reconciliation
Preliminary GAAP – Non - GAAP Reconciliation 18 © 2022 The Joint Corp. All Rights Reserved. $ in 000s
Slide 19: Contact Information
Jake Singleton, CFO jake.singleton@thejoint.com The Joint Corp. | 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245 - 5960 https://www.facebook.com/thejointchiro @ thejointchiro https://twitter.com/thejointchiro @ thejointchiro https://www.youtube.com/thejointcorp @ thejointcorp Pe